Vanguard Amends Vaxart Stake; Passive Ownership Update Filed
Ticker: VXRT · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 72444
| Field | Detail |
|---|---|
| Company | Vaxart, Inc. (VXRT) |
| Form Type | SC 13G/A |
| Filed Date | Feb 13, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**Vanguard updated its Vaxart holdings, signaling a passive stake adjustment.**
AI Summary
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, indicating a change in its holdings of Vaxart Inc. common stock as of December 29, 2023. This filing updates their previous disclosure, showing their continued significant, though potentially adjusted, passive ownership in the biotechnology company. This matters to investors because Vanguard's substantial stake can influence Vaxart's stock stability and signals institutional confidence (or lack thereof) in the company's future.
Why It Matters
This filing reveals an update to a major institutional investor's position in Vaxart, which can impact market perception and liquidity for the stock.
Risk Assessment
Risk Level: low — This is a routine amendment by a passive institutional investor and does not indicate any immediate, significant risk to Vaxart.
Analyst Insight
Investors should note that a major institutional holder like Vanguard continues to hold a stake in Vaxart, suggesting a baseline level of institutional interest, but this filing alone doesn't provide a strong buy or sell signal.
Key Players & Entities
- Vaxart Inc. (company) — the issuer of the securities
- The Vanguard Group (company) — the reporting person and institutional investor
- December 29, 2023 (date) — date of the event requiring the filing
- February 13, 2024 (date) — date the SC 13G/A was filed
Forward-Looking Statements
- Vanguard will maintain a significant, passive stake in Vaxart Inc. for the foreseeable future. (The Vanguard Group) — high confidence, target: 2025-02-13
FAQ
What is the purpose of an SC 13G/A filing?
An SC 13G/A is an amendment to a Schedule 13G, which is filed by passive institutional investors who own 5% or more of a company's stock. The '/A' indicates it's an amendment to a previously filed statement, updating information such as changes in ownership percentage or other disclosures.
Who is the reporting person in this specific filing?
The reporting person in this SC 13G/A filing is The Vanguard Group, identified by IRS Identification No. 23-1945930.
What is the subject company whose securities are being reported on?
The subject company is Vaxart Inc., with the Title of Class of Securities being Common Stock and CUSIP Number 92243A200.
When was the event that triggered this amendment?
The date of the event which requires the filing of this statement was December 29, 2023.
Under which rule was this Schedule 13G/A filed?
This Schedule 13G/A was filed under Rule 13d-1(b) of the Securities Exchange Act of 1934, as indicated by the checked box in the filing.
Filing Stats: 810 words · 3 min read · ~3 pages · Grade level 11.3 · Accepted 2024-02-13 17:16:04
Filing Documents
- tv02191-vaxartinc.htm (SC 13G/A) — 11KB
- 0001104659-24-022213.txt ( ) — 13KB
(a) - Name of Issuer
Item 1(a) - Name of Issuer: Vaxart Inc
(b) - Address of Issuer's Principal Executive Offices
Item 1(b) - Address of Issuer's Principal Executive Offices: 170 Harbor Way, Suite 300 South San Francisco, CA 94080
(a) - Name of Person Filing
Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930
(b) – Address of Principal Business Office or, if none, residence
Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355
(c) – Citizenship
Item 2(c) – Citizenship: Pennsylvania
(d) - Title of Class of Securities
Item 2(d) - Title of Class of Securities: Common Stock
(e) - CUSIP Number
Item 2(e) - CUSIP Number 92243A200
- Type of Filing
Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).
- Ownership
Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.
- Ownership of Five Percent or Less of a Class
Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following
- Ownership of More Than Five Percent on Behalf of Another Person
Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable
- Identification and Classification of Members of Group
Item 8 - Identification and Classification of Members of Group: Not applicable
- Notice of Dissolution of Group
Item 9 - Notice of Dissolution of Group: Not applicable
- Certification
Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration